FendX Technologies Inc. announced that the Company has successfully completed the first phase of development outlined in the development stage agreement with Dunmore International Corp. ("Dunmore"). Pursuant to the development stage agreement, the first phase was for Dunmore to adapt McMaster's lab prototype formulation for making REPELWRAPTM film to Dunmore's manufacturing production processes, which Dunmore has successfully completed.

The films created at Dunmore under the first phase were then tested at McMaster and McMaster confirmed the films to have similar repelling properties to the McMaster lab prototype. These positive findings allow Dunmore to advance to the next phase of development that entails conducting small runs on their commercial manufacturing line to create intermediate sized films for further testing. Being able to ultimately automate the manufacturing process for REPELWRAPTM film would be a key step in leading to the development of a commercial product.

REPELWRAPTM film is the Company's first product under development and is a protective surface coating film that leverages the Company's award-winning nanotechnology. REPELWRAPTM film has demonstrated unique repelling properties that prevent the adhesion of pathogens, bacteria, and viruses, reducing their transmission on surfaces prone to contamination. The Company believes REPELWRAPTM film will have applications in healthcare settings and other industries.